Is Swiss Chems Legit? FDA Letter, Lab Tests and Records
Is Swiss Chems legit? On record is a United States FDA warning letter from December 2024. It named two of the site’s products as unapproved new drugs. This page quotes that letter, then lays the other records beside it.
In short: the brand runs two domains, sells far more than peptides, carries a small and mixed independent test record, and has had its Trustpilot profile taken down. None of that is a verdict from us.
Each item below is sourced and dated, so you can read the warning letter and the test record for yourself.
The FDA Warning Letter
The most important record here is public and dated. The FDA’s warning-letter database holds a letter to “Swisschems”, reference MARCS-CMS 695663, issued on 10 December 2024 by the Center for Drug Evaluation and Research. It is addressed to Swisschems at 42 Broadway, 12th Floor, New York, New York 10004, and lists the contact email used by the store.
The substance is plain. The letter states that the website offered “Semaglutide” and “Retatrutide” products for sale in the United States, and that those products are unapproved new drugs introduced or delivered for introduction into interstate commerce, which the FDA says breaks federal law. It also notes that the agency reviewed the brand’s Facebook page. A “research chemicals only” label on a site does not change how the FDA treated these listings.
A warning letter is the agency stating its position to a seller; it is not a court ruling. We did not find a record of any response or follow-up action, so we report the letter itself and leave the rest open. Peptides Vietnam covers two other sellers with a letter on file, in the Peptide Partners review and the Prime Peptides review.
Sources: FDA warning letter to Swisschems (MARCS-CMS 695663)
Swiss Chems in Numbers
| Record item | Detail |
|---|---|
| FDA warning letter | Yes, dated 10 Dec 2024 |
| Finnrick tests on file | 10 |
| Scored a pass | 4 |
| Scored below the bar | 6 |
| Pass share | 40% |
| Newest listed result | 28 Apr 2026 |
| Rank among Finnrick vendors | #471 of 482 |
| Main domain (.is) first registered | 25 Jun 2020 |
| Trustpilot profile | Profile removed by Trustpilot |
The pass and fail counts are Finnrick’s own purity ratings, not a verdict that any product is genuine or fake.
Sources: FDA warning letter; Finnrick vendor page; RDAP domain record; Trustpilot
What the Site Sells
Swiss Chems is not only a peptide shop. Its public test-results page, read on 22 October 2026, lists products well outside peptides, including the SARM GW-501516 (sold as Cardarine), letrozole, enclomiphene and phenibut, each with a report link. The catalog mixes research peptides with hormone-pathway compounds and nootropic-type chemicals under one roof.
Why that matters for a review: the FDA letter named only the two GLP-1 products, semaglutide and retatrutide, not the wider catalog. The brand does post its own report PDFs on that page, but they are documents the seller chose to publish rather than independent results.
Independent Lab Tests
For results the seller did not commission, we used Finnrick, a blind-test leaderboard. Its Finnrick page listed 10 tests across 3 peptides when we read it on 22 October 2026: 4 rated a pass and 6 below the bar, the newest from 28 April 2026. That works out to a 40 percent pass share and a rank of #471 of 482, close to the bottom, on a small sample.
Keep the size in mind. Ten tests is a thin record, so a few results swing the percentage a lot, and one fail reflects a purity score, not a safety ruling. The honest read is that there is not much independent data here, and what exists leans more fail than pass. To learn how a blind-test result is produced, see our Janoshik testing guide.
Sources: Finnrick vendor page
Two Domains, One Removed Profile
The brand runs more than one address. Domain records show swisschems.com was registered on 25 August 2018, while swisschems.is was registered on 25 June 2020. The .is ending is Iceland’s country code and is a registration choice, not a sign of a Swiss or Icelandic head office. The FDA letter was aimed at the .is site.
On 22 October 2026 the Trustpilot page for swisschems.is shows “This profile has been removed”. Trustpilot points to its guidelines without saying what was breached.
Sources: RDAP (swisschems.com and swisschems.is); Trustpilot (swisschems.is)
Buying After a Warning Letter
A warning letter changes what a careful check looks like. These steps apply to any seller that has one, and none of them asks you to email the seller for paperwork.
- Read the letter at the source. The FDA publishes the full text, so you can see exactly which products and claims drew it.
- Separate the paperwork from the product. Self-posted report PDFs are the seller’s own; a blind-test index such as Finnrick is independent.
- Weigh the catalog. It spans SARMs and hormone-pathway chemicals beyond peptides, not a narrow peptide range.
- Check the review platform by exact domain, and note when a profile has been removed rather than guessing why.
Disclosure
Some links on this page are referral links. Peptides Vietnam may earn a fee at no cost to you. Editorial content is never sold.
Peptara Labs keeps a certificate of analysis for every item in its catalog at peptaralabs.io/coa.
What We Could Not Confirm
- Whether Swiss Chems responded to the FDA letter or faced any later action, which we found no record of.
- The operating company behind the brand, since we found no published business registration beyond the New York mailing address.
- Where orders actually ship from, which the site does not state.
- The detail behind the Trustpilot guideline breach, which the platform does not spell out.
Frequently Asked Questions
Is Swiss Chems legit?+
The clearest item on record is an FDA warning letter dated 10 December 2024, which told the seller that its "Semaglutide" and "Retatrutide" products are unapproved new drugs. Beyond that: the .com domain dates to 2018 and the .is domain to 2020, Finnrick lists 10 independent tests with 4 rated a pass and 6 below its bar, and the Trustpilot profile for swisschems.is has been removed by the platform. We do not score sellers; those are the checkable facts, and the reader decides.
Did Swiss Chems get an FDA warning letter?+
Yes. The FDA warning-letter database lists a letter to "Swisschems", reference MARCS-CMS 695663, dated 10 December 2024, from the Center for Drug Evaluation and Research. It states that the website offered "Semaglutide" and "Retatrutide" products for sale in the United States and that those products are unapproved new drugs introduced into interstate commerce, and it says the FDA also reviewed the Facebook page. The letter is addressed to Swisschems at 42 Broadway, 12th Floor, New York, New York 10004.
Where does Swiss Chems ship from?+
The store does not publish a shipping origin that we could confirm, so this stays unknown. What is on record is an address, not a warehouse: the FDA letter is addressed to Swisschems at 42 Broadway, 12th Floor, New York, New York 10004, and the site itself lists an email and a United States phone. An address on a letter is not proof of where parcels leave from, so we report it as the letter’s address and nothing more.
Where is Swiss Chem Labs located?+
There is no "Swiss Chem Labs" entity on the records we read; the name on the FDA letter is simply "Swisschems", at a New York mailing address. The brand runs two domains, swisschems.com (registered 2018) and swisschems.is (registered 2020), and the .is ending is an Iceland country code rather than a statement of a Swiss or Icelandic office. We did not find a published company registration, so the operator beyond the New York address is not established in our checks.
What do Swiss Chems lab tests show?+
On Finnrick, which collects independent lab results, the vendor has 10 tests across 3 peptides, of which 4 are rated a pass and 6 fall below its purity bar, the most recent dated 28 April 2026. That is a small record, and Finnrick ranks the vendor #471 of 482. In Finnrick terms a fail means a sample missed its purity bar, which is not the same as calling a product counterfeit. The site also posts its own test PDFs, but a seller controls what it publishes, so an independent index carries more weight.
Is Swiss Chems a trusted company?+
We do not give a trust verdict, so here is what the record holds. The FDA issued a warning letter on 10 December 2024, naming two of its products as unapproved new drugs. The independent test record is small and mixed, 4 of 10 rated a pass. The Trustpilot profile for swisschems.is has been removed by the platform. Weigh those signals against your own needs before buying.
Sources
- 1.FDA warning letter to Swisschems, MARCS-CMS 695663, dated 10 December 2024, Center for Drug Evaluation and Research, read on fda.gov on 22 October 2026: states the site offered Semaglutide and Retatrutide products in the United States as unapproved new drugs, notes a Facebook review, addressed to Swisschems at 42 Broadway, 12th Floor, New York, New York 10004
- 2.RDAP records: swisschems.com registered 25 August 2018, swisschems.is registered 25 June 2020
- 3.swisschems.is independent test results page, read 22 October 2026: a catalog beyond peptides including GW-501516 (Cardarine), letrozole, enclomiphene and phenibut, with self-posted report links
- 4.Finnrick vendor page for Swiss Chems, read 22 October 2026: 10 tests across 3 peptides, 4 rated a pass and 6 below the bar, latest 28 April 2026, vendor rank #471 of 482
- 5.Trustpilot profile for swisschems.is, read 22 October 2026: removed, a guideline breach stated with no detail, no live score shown
- 6.Peptara Labs certificate page: keeps a certificate of analysis for every item in its catalog
Not confirmed for this review: any response to the FDA letter, the operating company behind the brand, the true shipping origin, and the reason Trustpilot removed the profile. Anything we could not source on 22 October 2026 was left out.
Related Reading
Everything here is research, not medical advice, and it picks nothing for you to buy or use. The page gathers what the FDA database, domain records, the store’s own pages, and outside platforms held on 22 October 2026; statements the store makes about itself are flagged as its claims, and open questions are named as open. Any decision about your own health belongs with a pharmacist or a doctor.